FDA.reportPublic FDA data

lenvatinib 4 MG Oral Capsule

RxCUI
1604348
RxNorm name
lenvatinib 4 MG Oral Capsule
Display name
lenvatinib 4 MG Oral Capsule
Full name
lenvatinib 4 MG Oral Capsule
Term type
SCD
Status
DailyMed mapping
Updated
2026-06-04 23:39:28

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
LenvimaLENVATINIBEisai Inc.f4bedd21-efde-44c6-9d9c-b48b78d7ed1e2026-06-30Warnings, Adverse reactionsExact identifier
rxcui: 1604348

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
f4bedd21-efde-44c6-9d9c-b48b78d7ed1elenvatinib 4 MG Oral Capsule [PSN] · lenvatinib 4 MG Oral Capsule [SCD] · lenvatinib 4 MG (as lenvatinib mesylate 4.9 MG) Oral Capsule [SY]378These highlights do not include all the information needed to use LENVIMA safely and effectively. See full prescribing information for LENVIMA . LENVIMA ® ( lenvatinib ) capsules , for oral use Initial U.S. Approval: 201520250103